OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.07-0.07-0.52-0.81
Low Estimate-0.07-0.07-0.52-0.81
High Estimate-0.07-0.07-0.52-0.81
Year Ago EPS-0.21-0.21-0.53-0.52
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201612/30/20163/30/20179/29/2017
EPS Est.-0.24-0.19-0.3-0.08
EPS Actual-0.21-0.21-0.21-0.08
Difference0.03-0.020.090
Surprise %12.50%-10.50%30.00%0.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.07-0.07-0.52-0.81
7 Days Ago-0.07-0.07-0.52-0.81
30 Days Ago-0.07-0.07-0.52-0.81
60 Days Ago00-1.55-0.5
90 Days Ago00-1.55-0.5
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesOHRPIndustrySectorS&P 500
Current Qtr.66.70%N/AN/A0.26
Next Qtr.66.70%N/AN/A0.34
Current Year1.90%N/AN/A0.09
Next Year-55.80%N/AN/A0.15
Next 5 Years (per annum)91.50%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A